Multimodal imaging in type 2 idiopathic macular telangiectasia

Ferenc B Sallo1, Irene Leung, Traci E Clemons

  • 1*Department of Research and Development, Moorfields Eye Hospital, London, United Kingdom; †UCL Institute of Ophthalmology, London, United Kingdom; ‡The EMMES Corporation, Rockville, Maryland; §NIHR Biomedical Research Center for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom; ¶Inherited Eye Disease, Moorfields Eye Hospital, London, United Kingdom; **Department of Ophthalmology, St. Franziskus Hospital, Münster, Germany.

Retina (Philadelphia, Pa.)
|November 21, 2014
PubMed
Abstract